Compare ARK Genomic Revolution ETF (ARKG) vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF (PDBC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $16.42. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | PDBC | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $18.91 |
52-Week Low | $23.09 | $12.90 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
PDBC trades at $16.44, up 0.12% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The ETF has delivered strong returns, including a 37% gain since March 2024, outperforming the S&P 500. Recent news highlights its role as a diversified commodity strategy without K-1 tax forms, though momentum has weakened amid oil price declines and geopolitical tensions.
The outlook remains favorable for inflation hedging, but risks include commodity volatility and unpredictable distributions. Wall Street sentiment is mixed, with a recent downgrade to hold citing fading momentum. Key support sits at $16, with resistance at $17, indicating limited near-term upside without a breakout.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →
